title: Use of statin during hospitalization improves the outcome after intracerebral hemorrhage.
abstract: OBJECTIVE
  To examine the relationship between statin use in Chinese patients with intracerebral hemorrhage (ICH) during their hospitalization and the outcomes.
  
  
  METHODS
  Data were collected from the China National Stroke Registry. Good functional outcome was defined by a modified Rankin Scale score between 0-2. Functional outcome and rate of mortality at 3 months and 1 year were compared between ICH patients on statin and those without it during their hospitalization. Odds ratios (ORs) with 95% confidence intervals (CI) were calculated using the multivariable logistic regression model adjusted for baseline risk factors.
  
  
  RESULTS
  Among 3218 consecutive ICH patients from 2007 to 2008, 220 (6.8%) were on statin during their hospitalization. Compared with those without statin, patients on statin were younger, had more stroke risk factors but lower stroke severity. ICH patients on statin had better functional outcome at 3 months (OR 2.24, 95% CI 1.49-3.36) and at 1 year (OR 2.04, 95% CI 1.37-3.06). They also had lower rate of mortality at 3 months (OR 0.44, 95% CI 0.22-0.87) and 1 year (OR 0.49, 95% CI 0.27-0.86).
  
  
  CONCLUSIONS
  In-hospital statin use in ICH patients is associated with better functional outcome and lower mortality at 3 months and 1 year.
authors.affiliation: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
authors.forename: Yue-Song
authors.initials: YS
authors.lastname: Pan
authors.forename: Jing
authors.initials: J
authors.lastname: Jing
authors.forename: Yi-Long
authors.initials: YL
authors.lastname: Wang
authors.forename: Xing-Quan
authors.initials: XQ
authors.lastname: Zhao
authors.forename: Bo
authors.initials: B
authors.lastname: Song
authors.forename: Wen-Juan
authors.initials: WJ
authors.lastname: Wang
authors.forename: David
authors.initials: D
authors.lastname: Wang
authors.forename: Gai-Fen
authors.initials: GF
authors.lastname: Liu
authors.forename: Li-Ping
authors.initials: LP
authors.lastname: Liu
authors.forename: Chun-Xue
authors.initials: CX
authors.lastname: Wang
authors.forename: Yong-Jun
authors.initials: YJ
authors.lastname: Wang
mesh_terms: D000368:Aged; D002543:Cerebral Hemorrhage / Q000628:therapy*; D002681:China; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D012042:Registries; D012189:Retrospective Studies; D012307:Risk Factors; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Hemorrhagic stroke; Intracerebral hemorrhage; Outcome; Statin
references.citation: Neurology. 2008 Jun 10;70(24 Pt 2):2364-70
references.pmid: 18077795
references.citation: Cent Eur Neurosurg. 2009 Feb;70(1):15-20
references.pmid: 19197830
references.citation: Neurosurg Rev. 2013 Apr;36(2):279-87; discussion 287
references.pmid: 23097148
references.citation: Arch Neurol. 2012 Jan;69(1):39-45
references.pmid: 21911657
references.citation: Lancet Neurol. 2012 Aug;11(8):720-31
references.pmid: 22698888
references.citation: Stroke. 2013 Jul;44(7):2058-9
references.pmid: 23765947
references.citation: Stroke. 2012 Aug;43(8):2149-56
references.pmid: 22588266
references.citation: Stroke. 2009 Jul;40(7):2581-4
references.pmid: 19407227
references.citation: J Stroke Cerebrovasc Dis. 2013 Nov;22(8):e541-5
references.pmid: 23867041
references.citation: Stroke. 2013 Jul;44(7):2060-1
references.pmid: 23765946
references.citation: Eur J Neurol. 2010 Mar;17(3):443-8
references.pmid: 19912325
references.citation: Stroke. 2009 Oct;40(10):3384-9
references.pmid: 19644071
references.citation: J Neurosurg. 2004 Jul;101(1):104-7
references.pmid: 15255259
references.citation: Eur J Neurol. 2010 Jan;17(1):78-83
references.pmid: 19614959
references.citation: Stroke. 2006 Jan;37(1):63-8
references.pmid: 16306469
references.citation: Stroke. 1989 Oct;20(10):1407-31
references.pmid: 2799873
references.citation: Stroke. 2013 May;44(5):1472-6
references.pmid: 23444304
references.citation: Stroke. 2012 Jun;43(6):1518-23
references.pmid: 22442172
references.citation: CNS Neurosci Ther. 2012 Sep;18(9):773-80
references.pmid: 22943144
references.citation: Neurosci Lett. 2000 Apr 14;283(3):230-2
references.pmid: 10754230
references.citation: Neurocrit Care. 2008;8(1):6-12
references.pmid: 17701108
references.citation: Brain Res. 2000 Jul 14;871(1):57-65
references.pmid: 10882783
references.citation: Stroke. 2013 Aug;44(8):2330-2
references.pmid: 23760210
references.citation: Acta Neurochir Suppl. 2012;114:343-6
references.pmid: 22327720
references.citation: Neurology. 2011 May 3;76(18):1581-8
references.pmid: 21451150
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: N Engl J Med. 2001 May 10;344(19):1450-60
references.pmid: 11346811
references.citation: Med Care. 2007 Oct;45(10 Supl 2):S158-65
references.pmid: 17909375
references.citation: Int J Stroke. 2011 Aug;6(4):355-61
references.pmid: 21609414
references.citation: Stroke. 2013 Jul;44(7):2062-3
references.pmid: 23765948
references.citation: Stroke. 2008 Jul;39(7):2151-4
references.pmid: 18436876
references.citation: Stroke. 2004 Jul;35(7):1744-9
references.pmid: 15166393
references.citation: Stroke. 2008 Jun;39(6):1668-74
references.pmid: 18309149